The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children

British Journal of Nutrition
Q1
May 2009
Citations:73
Influential Citations:1
Interventional (Human) Studies
84
S2 IconPDF Icon

Enhanced Details

Methods
Double-blind randomized placebo-controlled trial in apparently healthy prepubertal children aged 6-10 years; 55 participants (27 placebo, 28 MK-7) from two primary schools around Utrecht, The Netherlands.
Intervention
MK-7 (menaquinone-7) 45 mg daily for 8 weeks, delivered in capsules with linseed oil; taken once daily with the main evening meal.
Results
MK-7 supplementation for 8 weeks reduced inactive ucOC and improved the ucOC:cOC ratio (UCR), with MK-7 serum levels rising; carboxylated OC (cOC) increased modestly but not significantly. Placebo showed no significant changes; bone turnover markers and coagulation parameters remained unchanged in both groups. Conclusion: MK-7 at this dose improves vitamin K status and is safe in healthy prepubertal children; additional dose-finding and longer-term trials are needed to define optimal dosing and confirm potential bone-health benefits.
Limitations
Not dose-finding; small sample size; no assessment of habitual dietary vitamin K intake; some missing lab data due to venipuncture failures; short duration; results may not generalize beyond healthy prepubertal children.

Abstract

Vitamin K contributes to bone health, probably through its role as cofactor in the carboxylation of osteocalcin. Intervention studies in adults have demonstrated that markedly higher osteocalcin carboxylation is obtained by intakes of vitamin K well ...